Cellebrite DI (CLBT) vs Infleqtion (INFQ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cellebrite DI is the larger company by market cap ($2.85 billion vs $2.51 billion), about 1.1 times the size. Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus -103.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLBT | INFQ |
|---|---|---|
| Share price | $11.34 | $11.16 |
| Market cap | $2.85B | $2.51B |
| 1-day change | +1.02% | -4.12% |
| YTD return | -37.74% | — |
| 1-year return | -39.29% | — |
| 5-year return | +8.24% | — |
| P/E ratio (TTM) | 49.30 | — |
| Forward P/E | 17.36 | — |
| EPS (TTM) | $0.23 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $475.68M | $31.11M |
| Revenue growth (YoY) | +18.56% | +10.73% |
| Net income (latest FY) | $78.33M | $-32.23M |
| Gross margin | 84.20% | 36.58% |
| Operating margin | 13.98% | -114.82% |
| Net margin | 16.47% | -103.60% |
| 52-week high | $19.98 | $21.28 |
| 52-week low | $9.58 | $8.52 |
| Distance from 52-week high | -43.24% | -47.56% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +35.45% | +95.61% |
| Average volume | 2.96M | 8.86M |
| Shares outstanding | 251.34M | 225.36M |
| Employees | 1,285 | 203 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus -103.6 cents for Infleqtion.
- Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs +10.73%).
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
About Infleqtion
INFQ stock →Infleqtion, Inc. engages in the development and commercialization of quantum technology products in the United States, Europe, and Asia.
Technology · EDP Services · 203 employees
CLBT vs INFQ FAQ
Which is bigger, Cellebrite DI or Infleqtion?
Cellebrite DI (CLBT) is larger, with a market capitalization of $2.85B compared with $2.51B for Infleqtion (INFQ).
Are Cellebrite DI and Infleqtion in the same industry?
Both are in the Technology sector, but in different industries: Computer Software: Prepackaged Software for Cellebrite DI and EDP Services for Infleqtion.